Newsroom

Biotechnology

Explore the latest breakthroughs and trends in the Biotechnology sector with our newsroom. From cutting-edge innovations in gene therapy and biopharmaceuticals to advancements in medical research and regulatory updates, we provide essential insights into the scientific developments shaping the future of healthcare and life sciences.


Latest Press Releases

Milestone Scientific to Present at The LD 500 Virtual Conference on September 1st
BiotechnologyConferences

Milestone Scientific to Present at The LD 500 Virtual Conference on September 1st

August 27, 2020 8:30 AM

ROSELAND, NJ / ACCESSWIRE / August 27, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at The LD 500 Investor conference being held virtually on September 1-4, 2020. Len Osser, Interim Chief Executive Officer, is scheduled to present on Tuesday, September 1st at 2:40 p.m., Eastern Time. The...

Read more
Tetra Bio-Pharma Announces Data on its CBD Metabolite Study in Humans
BiotechnologyCompany Update

Tetra Bio-Pharma Announces Data on its CBD Metabolite Study in Humans

August 27, 2020 8:00 AM

Tetra defines CBD Metabolism in Humans Following QIXLEEF™ Inhalation Data from metabolite study provides explanation for inhalation as a safe route of administration OTTAWA, ON / ACCESSWIRE / August 27, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced that it has mapped out CBD metabolites in humans who were administered...

Read more
Artelo Biosciences to Present at The LD 500 Virtual Investor Conference on September 1st
BiotechnologyConferences

Artelo Biosciences to Present at The LD 500 Virtual Investor Conference on September 1st

August 26, 2020 9:30 AM

LA JOLLA, CA / ACCESSWIRE / August 26, 2020 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the LD 500 Virtual Investor conference being held on September 1-4, 2020. View Artelo's LD Micro profile here: https://www.ldmicro.com/profile/artl. Gregory D. Gorgas, President and Chief Executive...

Read more
GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, Utilizing Its Cannabinoid Containing Complex Mixtures (CCCM(TM))
BiotechnologyCompany Update

GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, Utilizing Its Cannabinoid Containing Complex Mixtures (CCCM(TM))

August 26, 2020 9:00 AM

LAS VEGAS, NV / ACCESSWIRE / August 26, 2020 / GB Sciences, Inc. (OTCQB:GBLX) has filed a provisional patent application, assigned to GBS Global Biopharma (GBS), Inc., for the use of its new proprietary cannabinoid containing complex mixtures (CCCM™) for the treatment of Cytokine Storm Syndromes (CSS), including acute respiratory distress syndrome (ARDS) in COVID-19 patients. CSS and ARDS are the leading cause of death in COVID-19. Based on...

Read more
Genprex to Present at The LD 500 Virtual Conference
BiotechnologyConferences

Genprex to Present at The LD 500 Virtual Conference

August 26, 2020 8:17 AM

AUSTIN, TX / ACCESSWIRE / August 26, 2020 / Genprex, Inc. ("Genprex" or the "Company") (NASDAQ:GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it will be presenting at the LD 500 Virtual Investor Conference on Tuesday, September 1, 2020 at 1:20 p.m. ET. Rodney Varner, Chairman and Chief Executive Officer of Genprex, will present virtually...

Read more
electroCore to Present at The LD 500 Virtual Conference
BiotechnologyConferences

electroCore to Present at The LD 500 Virtual Conference

August 26, 2020 8:00 AM

LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / electroCore Inc, (NASDAQ:ECOR), a commercial-stage bioelectronic medicine company, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 6:20 AM PST / 9:20 AM EST. Dan Goldberger, Chief Executive Officer of electroCore, will be presenting to a live audience. Register here: https://ld-micro-conference.events.issuerdirect.com/ "We have been...

Read more
Molecular Partners Reports Corporate Highlights and Key Financials for H1 2020
BiotechnologyInvestor Relations

Molecular Partners Reports Corporate Highlights and Key Financials for H1 2020

August 26, 2020 1:00 AM

Research & Development: Developed novel anti-COVID-19 multi-specific DARPin® candidates, of which MP0420 is being prepared for clinical trial initiation in Q4 2020. Initial in vitro and in vivo data highly supportive of unique mechanisms of action with ultra-potent anti-viral activity seen. Secured partnership with AGC Biologics to meet initial projected clinical and commercial-scale manufacturing capacity for anti-COVID-19 program. In...

Read more
Hancock Jaffe Enrolls Initial Patients for First-in-Human CoreoGraft Study
BiotechnologyCompany Update

Hancock Jaffe Enrolls Initial Patients for First-in-Human CoreoGraft Study

August 25, 2020 11:00 AM

Two of Five Patients Enrolled for the Study IRVINE, CA / ACCESSWIRE / August 25, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has enrolled the first two patients for its first-in-human CoreoGraft study. The first implant of the CoreoGraft conduits will take place in the coming weeks and HJLI will announce the schedule when available. The...

Read more
Experion Set to Introduce Vegan Gummies Under Citizen Stash
BiotechnologyCompany Update

Experion Set to Introduce Vegan Gummies Under Citizen Stash

August 25, 2020 8:45 AM

Experion Signs Supply Agreement with Lyf Food Technologies Inc. VANCOUVER, BC / ACCESSWIRE / August 25, 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce it has signed a supply agreement with Lyf Food Technologies Inc. ("Lyf") for the supply of high quality edible cannabis products. Under the terms of the Agreement, Lyf Food Technologies will supply Experion...

Read more
PharmaNest Announces New Pre-Clinical and Clinical NASH Data to Be Presented at the EASL | Digital International Liver Congress 2020
BiotechnologyProduct Announcements

PharmaNest Announces New Pre-Clinical and Clinical NASH Data to Be Presented at the EASL | Digital International Liver Congress 2020

August 24, 2020 4:00 PM

PRINCETON, NJ / ACCESSWIRE / August 24, 2020 / ​​​​​PharmaNest is an image analysis company focused in the development and validation of novel standards for the quantification of Fibrosis and associated histological features for drug discovery and development. Recently, PharmaNest announced the launch of its FibroNest cloud-based and multi-vendor platform for the automated quantification of Fibrosis for non-alcoholic fatty liver disease (NAFLD)...

Read more
Nascent Biotech Inc Completes $740,000 Equity Round of Funding
BiotechnologyCompany Update

Nascent Biotech Inc Completes $740,000 Equity Round of Funding

August 24, 2020 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / August 24, 2020 / Nascent Biotech, Inc (OTCQB:NBIO) announced today that it is closing on a direct private placement with aggregate proceeds of $740,000. The proceeds allow the Company to complete the required testing for removing the partial clinical trial hold, imposed by the FDA, and will permit the company to begin the Phase I clinical trials on brain cancer. Sean Carrick, CEO of Nascent commented, "The...

Read more
Wuhan General Group Corporate Update
BiotechnologyCompany Update

Wuhan General Group Corporate Update

August 21, 2020 11:45 AM

CAPE TOWN, SA / ACCESSWIRE / August 21, 2020 / WUHAN GENERAL GROUP, INC. (OTC Pink:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is delighted to share the following corporate update: Supply Chain, Operations and Covid-19: August 18th, South Africa transitioned from level 3 lockdown to level 2 with many restrictions being lifted amid its battle with...

Read more
Hancock Jaffe Announces One Year Follow-up Data on Two Additional VenoValve Patients
BiotechnologyCompany Update

Hancock Jaffe Announces One Year Follow-up Data on Two Additional VenoValve Patients

August 21, 2020 8:30 AM

VenoValve Patients Continue to Show Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / August 21, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that two additional VenoValve patients from HJLI's first-in-man, clinical study in Colombia have now reached the one-year milestone following VenoValve surgery, and that chronic venous...

Read more
Rising Biosciences, Inc. Announces Shareholder Conference Call, Wednesday, August 26th
BiotechnologyCompany Update

Rising Biosciences, Inc. Announces Shareholder Conference Call, Wednesday, August 26th

August 20, 2020 9:00 AM

SANDUSKY, OH / ACCESSWIRE / August 20, 2020 / Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall is extending an invitation to a shareholder conference call at 4:30 PM EDT on Wednesday, August 26th. "Shareholders and people following RBII are invited to participate", said Hall. "We have experienced solid growth in 2020 and we're excited to answer questions, share our enthusiasm and discuss what the coming months will bring. We'll have...

Read more
Lexaria Bioscience to Present at the LD 500 Virtual Conference
BiotechnologyConferences

Lexaria Bioscience to Present at the LD 500 Virtual Conference

August 20, 2020 7:17 AM

Company to discuss its Phase I R&D program with Altria Ventures Inc., for oral forms of nicotine delivery utilizing its patented DehydraTECH™ technology LOS ANGELES, CA / ACCESSWIRE / August 20, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it will be presenting at the 12th annual LD 500 Conference on Tuesday, September 1, 2020 at 12:00...

Read more
National Comprehensive Cancer Network(R) Adds Monjuvi(R) (tafasitamab-cxix) to its Clinical Practice Guidelines in Oncology for B-cell Lymphomas
BiotechnologyCompany Update

National Comprehensive Cancer Network(R) Adds Monjuvi(R) (tafasitamab-cxix) to its Clinical Practice Guidelines in Oncology for B-cell Lymphomas

August 18, 2020 4:24 PM

PLANEGG/MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / August 18, 2020 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR) and Incyte (Nasdaq:INCY) today announced that Monjuvi® (tafasitamab-cxix), a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, has been included in the latest National Comprehensive Cancer Network® Clinical Practice Guidelines (NCCN Guidelines®) in Oncology for B-cell Lymphomas....

Read more
Green Leaf Farms International Signs Joint Venture Agreement with ST Biosciences for Its Project in Argentina
BiotechnologyCompany Update

Green Leaf Farms International Signs Joint Venture Agreement with ST Biosciences for Its Project in Argentina

August 18, 2020 8:30 AM

The Agreement includes an investment of $1.2 million and distribution of GLFIs products to ST Biosciences International Customers LAS VEGAS, NV / ACCESSWIRE / August 18th, 2020 / GLFI, Inc., doing business as Green Leaf Farms International a privately held company that is a majority owned subsidiary of Players Network, Inc. (OTC PINK:PNTV), which has been established to finance and manage international cannabis operations outside North...

Read more
AzurRx BioPharma to Present at The LD 500 Virtual Conference
BiotechnologyConferences

AzurRx BioPharma to Present at The LD 500 Virtual Conference

August 18, 2020 8:00 AM

LOS ANGELES, CA / ACCESSWIRE / August 18, 2020 / AzurRx BioPharma, Inc. (NASDAQ:AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it will be presenting at the LD 500 investor conference on Tuesday, September 1st at 2:20 PM Eastern Time/11:20 AM Pacific Time. AzurRx CEO and President James Sapirstein will be presenting to a live virtual audience and will be...

Read more
Tetra Bio-Pharma Engages Dalton Pharma for GMP Manufacturing of ARDS-003
BiotechnologyCompany Update

Tetra Bio-Pharma Engages Dalton Pharma for GMP Manufacturing of ARDS-003

August 18, 2020 8:00 AM

Significant advancement achieved with ARDS-003 sterile injectable nano-emulsion finished drug product A new anti-inflammatory drug candidate OTTAWA, ON / ACCESSWIRE / August 18, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has awarded the contract for the manufacturing of its active pharmaceutical ingredient...

Read more
Tetra Bio-Pharma and Mondias Enter Into Final Agreement For The Purchase Of Lumiera Health Innovation Inc.
BiotechnologyCompany Update

Tetra Bio-Pharma and Mondias Enter Into Final Agreement For The Purchase Of Lumiera Health Innovation Inc.

August 17, 2020 8:30 AM

MONTREAL, QC / ACCESSWIRE / August 17, 2020 / Mondias Natural Products Inc. (TSXV:NHP) (the "Company" or "Mondias") specializing in evidence-based natural products for the healthcare and bio-agriculture markets and Tetra Bio-Pharma Inc. ("Tetra"), (TSX-V:TBP) (OTCQB:TBPMF), a biopharmaceutical leader in the discovery and development of cannabinoid-derived therapeutics are pleased to announce they are entering into Definitive Agreement for the...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?